Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Clinical use of teriparatide in the real world: initial insightsPaul D Miller, John P Bilezikian, Chad Deal, et al.The Annals of Pharmacotherapy|March 26, 2009
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronateWilliam A Blumentals, Steven T Harris, Raymond E Cole, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 24, 2004
Classification algorithms for hip fracture prediction based on recursive partitioning methodsHua Jin, Ying Lu, Steven T Harris, et al.Mayo Clinic Proceedings|August 12, 2006
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesEthel S Siris, Steven T Harris, Clifford J Rosen, et al.Postgraduate Medicine|May 31, 2022
The role of osteoanabolic agents in the management of patients with osteoporosisMichael R McClung, Micol S Rothman, E Michael Lewiecki, et al.The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.The Journal of Rheumatology|October 6, 2005
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by ageMark P Ettinger, Dieter Felsenberg, Steven T Harris, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 13, 2017
Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of OsteoporosisE Michael Lewiecki, John P Bilezikian, John J Carey, et al.The American Journal of Medicine|November 27, 2012
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holidayMichael McClung, Steven T Harris, Paul D Miller, et al.Pageof 3